These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 390884

  • 41. [Significance of changes in blood serum hexosamines in the pathogenesis of diabetic microangiopathies].
    Riabchuk OG, Starosel'tseva LK.
    Sov Med; 1970 Mar; 33(3):21-4. PubMed ID: 5419171
    [No Abstract] [Full Text] [Related]

  • 42. The etiology of diabetic microangiopathy--a review of the recent literature.
    Smith CW.
    N C Med J; 1974 Jun; 35(6):354-5. PubMed ID: 4527229
    [No Abstract] [Full Text] [Related]

  • 43. [Study on the pathogenesis of diabetic retinopathy--observation on serum growth hormone].
    Zhu ZR.
    Zhonghua Yan Ke Za Zhi; 1984 Mar; 20(2):71-3. PubMed ID: 6435967
    [No Abstract] [Full Text] [Related]

  • 44. [Serum lipids and diabetic control with special reference to angiopathy (author's transl)].
    Morimoto M.
    Rinsho Byori; 1975 Jan; 23(1):1-6. PubMed ID: 1168267
    [No Abstract] [Full Text] [Related]

  • 45. [Importance of the plasma growth hormone level (HGH) on the development of diabetic retinopathy].
    Sévin R.
    Bull Mem Soc Fr Ophtalmol; 1972 Jan; 85(0):213-20. PubMed ID: 4671781
    [No Abstract] [Full Text] [Related]

  • 46. [GH, prolactin and microangiopathy in insulin-dependent diabetes].
    Cerutti F, Pagliero R, Ramenghi U, Sacchetti C, Baratono S, Altare F.
    Minerva Pediatr; 1981 Feb 15; 33(3):127-30. PubMed ID: 7242486
    [No Abstract] [Full Text] [Related]

  • 47. Hypophysectomy in diabetic retinopathy. The relationship between the degree of pituitary ablation and ocular response.
    Adams DA, Rand RW, Roth NH, Dashe AM, Gipstein RM, Heuser G.
    Diabetes; 1974 Aug 15; 23(8):698-707. PubMed ID: 4604549
    [No Abstract] [Full Text] [Related]

  • 48. [Method of determination of somatotropin level in blood plasma with L-dopa loading in patients with diabetes mellitus complicated by microangiopathies].
    Babakhanov KhB.
    Lab Delo; 1975 Aug 15; (10):605-7. PubMed ID: 54462
    [No Abstract] [Full Text] [Related]

  • 49. [SIGNIFICANCE OF PITUITARY AND ADRENAL CORTEX HORMONES IN DIABETES MELLITUS].
    TAKEDA R, MIYAHO S, MORIMOTO S, HASUI K, KANEDA M, NAGANO T, YOKOYAMA T.
    Nihon Rinsho; 1964 Apr 10; 22():835-44. PubMed ID: 14129792
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Complications of diabetes.
    Hunter P.
    Lancet; 1970 Aug 01; 2(7666):264. PubMed ID: 4193714
    [No Abstract] [Full Text] [Related]

  • 52. [Endocrine abnormalities in diabetes mellitus].
    Takeda R, Nakagawa A, Nakabayashi H.
    Nihon Rinsho; 1990 Dec 01; 48 Suppl():731-7. PubMed ID: 1964981
    [No Abstract] [Full Text] [Related]

  • 53. [Indicators of the blood kinin system in diabetes mellitus].
    Spesivtseva VG, Men'shikov VV, Beliakov NV, Mamaeva GG, Stepanova NI.
    Sov Med; 1976 Jun 01; (6):25-8. PubMed ID: 190712
    [No Abstract] [Full Text] [Related]

  • 54. [Renal structure and function in early and diabetes long-term].
    Lundbaek K.
    Rev Med Suisse Romande; 1970 Aug 01; 90(8):603-14. PubMed ID: 5500529
    [No Abstract] [Full Text] [Related]

  • 55. [Serum glycoproteins in diabetes mellitus; quantitative immunological determination of acid alpha 1-glycoprotein, Gc, alpha 2-macroglobulin and hemopexin in diabetics with and without angiopathy].
    Cleve H, Alexander K, Mitzkat HJ, Nissen P, Salzmann I.
    Diabetologia; 1968 Jan 01; 4(1):48-55. PubMed ID: 4984806
    [No Abstract] [Full Text] [Related]

  • 56. Evaluation of the effects of intravenous piribedil administration on somatotropic hormone and glucose equilibrium in the diabetic patient.
    Orsetti A, Cecarrini D, Mirouze J.
    Horm Metab Res; 1978 Nov 01; 10(6):561. PubMed ID: 744577
    [No Abstract] [Full Text] [Related]

  • 57. [Risk factors of developing diabetic complications].
    Hotta N, Sano T.
    Nihon Rinsho; 1991 Feb 01; 49 Suppl():9-17. PubMed ID: 2033883
    [No Abstract] [Full Text] [Related]

  • 58. [Growth hormone and delayed diabetic complications].
    Schatz H.
    Dtsch Med Wochenschr; 1984 Aug 03; 109(31-32):1181-2. PubMed ID: 6745122
    [No Abstract] [Full Text] [Related]

  • 59. Diabetes mellitus: can we reduce the complications?
    Malins JM.
    J R Coll Physicians Lond; 1976 Apr 03; 10(3):289-93. PubMed ID: 1263165
    [No Abstract] [Full Text] [Related]

  • 60. [Proliferative retinopathy at the onset of diabetes (author's transl)].
    Fischer F.
    Klin Monbl Augenheilkd; 1980 Mar 03; 176(3):453-6. PubMed ID: 7421012
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.